Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of British Columbia

$489,600.00

Copper Drug Complexes: Development of a novel class of drugs with significant potential for treatment of platinum insensitive cancers

EF 2016-17

Résumé
One strategy that Dr. Bally has been using to develop drug candidates for use in treating cancer involves repurposing drugs utilized for the treatment of diseases other than cancer; illnesses such as malaria, fungal infections or even alcoholism. He wants to repurpose these drugs for use in patients with cancer because they have unusual and unexpected ways of affecting cancer cell growth and survival. Further these drugs are very active in cancer cells that are resistant (insensitive) to one of the most commonly used drugs available to oncologist- cisplatin. Sadly, the useful form of these approved drugs is often water insoluble and cannot be injected into patients. Dr. Bally's team has solved this problem for many such drugs by synthesizing them inside small (100 times smaller than a red blood cell) spherical structure prepared from lipids. These structures are called liposomes ("lipid bodies"). Liposomes with entrapped drugs have been used successfully to improve the therapeutic effects of cancer drugs, but in the current research the liposomes are enabling the creation of the active drug inside the spherical structure in a manner which keeps the drug in solution; in a form that can be administered to patients. This research program will characterize and develop selected versions of these drugs for use in the treatment of cancers that are resistant or insensitive to cisplatin.
Programme
Project Grant
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
357858
Name
Bally Marcel B
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Project Grant Competition
Projecttitle
Copper Drug Complexes: Development of a novel class of drugs with significant potential for treatment of platinum insensitive cancers
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$489,600
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Anticancer Drugs; Copper; Drug Development; Formulation Development; Liposomes; Metal Complexes; Pharmacodynamics; Pharmacokinetics; Platinum Insensitive; Repurposing
Abstract
One strategy that Dr. Bally has been using to develop drug candidates for use in treating cancer involves repurposing drugs utilized for the treatment of diseases other than cancer; illnesses such as malaria, fungal infections or even alcoholism. He wants to repurpose these drugs for use in patients with cancer because they have unusual and unexpected ways of affecting cancer cell growth and survival. Further these drugs are very active in cancer cells that are resistant (insensitive) to one of the most commonly used drugs available to oncologist- cisplatin. Sadly, the useful form of these approved drugs is often water insoluble and cannot be injected into patients. Dr. Bally's team has solved this problem for many such drugs by synthesizing them inside small (100 times smaller than a red blood cell) spherical structure prepared from lipids. These structures are called liposomes ("lipid bodies"). Liposomes with entrapped drugs have been used successfully to improve the therapeutic effects of cancer drugs, but in the current research the liposomes are enabling the creation of the active drug inside the spherical structure in a manner which keeps the drug in solution; in a form that can be administered to patients. This research program will characterize and develop selected versions of these drugs for use in the treatment of cancers that are resistant or insensitive to cisplatin.
Competitiondate
201610
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Bally, Marcel B
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $489,600~ $0~